This is a study to evaluate the safety and efficacy of EIK1001 administered intravenously in combination with pembrolizumab and histologically appropriate chem…

Non Small Cell Lung Cancer (Squamous or Non Squamous)Stage 4 NSCLC

~Estimated

~$10 – $8,750

Eikon TherapeuticsNCT07365319

Phase 2

Phase II Trial of Thoracic Radiotherapy for Patients With Metastatic (Stage IV) Non-Small Cell Lung Cancer at High Risk of Symptomatic Progression Within the Thorax

Patients with metastatic non small cell lung cancer with high risk location or size are treated with prophylactic radiation therapy in conjunction with standar…

Stage 4 NSCLCRadiotherapy

~Estimated

~$10 – $6,250

University of RochesterNCT06262321